Evaluation of White Blood Cell- and Platelet-Derived Cytokine Accumulation in MIRASOL-PRT-Treated Platelets.
BACKGROUND: Soluble mediators in platelet concentrates (PCs) released from contaminating white blood cells (WBCs) and platelets (PLTs) themselves are supposed to promote allergic and non-hemolytic febrile transfusion reactions in the recipient. Pathogen reduction technologies (PRTs) prevent replication and proliferation of pathogens as well as of WBCs, and may reduce cytokine accumulation in PCs during storage and prevent adverse events after PLT transfusion. On the other hand, such treatments may also lead to increased cytokine production by stimulation of WBCs or PLTs due to the photochemical or photodynamical process itself. MATERIAL AND METHODS: 12 triple-dose PLT apheresis collections were leukoreduced by the process-controlled leukoreduction system of the Trima Accel machine and split into 3 units undergoing Mirasol-PRT treatment (M) or gamma irradiation (X) or remaining untreated (C). During storage for up to 7 days, PLT activation, WBC-derived Th-1/2, and inflammatory as well as PLT-derived cytokines were measured by cytometric bead array and enzymelinked immunosorbent assay, respectively. RESULTS: Independent of treatment, all PLT products exhibited low levels of WBC-associated cytokines near or below assay detection limits. WBC-associated cytokines were not elevated by Mirasol-PRT treatment. PLT-derived cytokines were detected at higher levels and increased significantly during storage in all units. Most likely due to higher PLT activation, M units showed significantly higher levels of PLT-derived cytokines compared to untreated and gamma-irradiated units on day 5 of storage. CONCLUSION: In all PCs, PLTs themselves were the main source of cytokine release. Mirasol-PRT treatment was associated with a significantly increased PLT activation and accumulation of PLT-derived cytokines during storage, without affecting WBC-derived cytokines relative to controls.
Picker
Susanne M
SM
Transfusion Medicine, University of Cologne, Germany.
Steisel
Alexander
A
Gathof
Birgit S
BS
J Immunol. 1992 Jul 15;149(2):636-42
1378073
Transfusion. 2005 Jun;45(6):920-6
15934990
Transfusion. 1999 Mar;39(3):231-8
10204584
Blood. 2004 Sep 1;104(5):1534-41
15138160
N Engl J Med. 1994 Sep 8;331(10):625-8
8052271
Microcirculation. 2003 Jun;10(3-4):335-50
12851650
Transfusion. 2002 May;42(5):556-66
12084163
Vox Sang. 2003 Jan;84(1):28-35
12542731
Vox Sang. 2006 May;90(4):279-85
16635070
Transfus Med. 2002 Oct;12(5):317-24
12383338
Vox Sang. 2002 Aug;83(2):125-36
12201842
Transfusion. 2006 May;46(5):800-10
16686848
Vox Sang. 2003 Oct;85(3):206-12
14516451
Transfusion. 2005 Jun;45(6):911-9
15934989
Transfusion. 2006 Apr;46(4):642-8
16584442
Transfusion. 2004 Mar;44(3):320-9
14996187
Vox Sang. 2002 May;82(4):182-90
12047512
Transfusion. 2004 Jan;44(1):10-5
14692961
Transfusion. 2004 Aug;44(8):1143-8
15265117
J Exp Med. 1992 Dec 1;176(6):1489-95
1281207
Vox Sang. 2004 Aug;87(2):82-90
15355498
Vox Sang. 2005 Apr;88(3):164-71
15787726
Transfusion. 1999 Nov-Dec;39(11-12):1179-84
10604243
Transfusion. 1999 Mar;39(3):239-48
10204585
Transfusion. 2004 Jan;44(1):16-24
14692962
J Cell Biol. 2001 Aug 6;154(3):485-90
11489912
Vox Sang. 1998;75(3):218-23
9852410
Biochem Pharmacol. 1987 Jun 1;36(11):1769-73
3579972
Transfusion. 2003 Aug;43(8):1038-46
12869108
Thromb Haemost. 1989 Dec 29;62(4):1100-2
2617457
Vox Sang. 2004 Apr;86(3):201-2
15078258
Transfusion. 1999 May;39(5):498-505
10336000
J Immunol. 1993 Apr 15;150(8 Pt 1):3442-8
7682241
Blood. 2003 Mar 15;101(6):2426-33
12456508